Abstract
Chronic pain is one of the leading health-care crises in America today, affecting more patients than cancer and heart disease combined. In response to uncontrolled pain, the use of prescription opioid analgesics has soared, resulting in a second problem, one of addiction. In order to optimally treat patients with pain, while minimizing the risks of abuse diversion or addiction, it is important to establish an accurate diagnosis and design the most appropriate treatment plan. Moreover there are multiple strategies that are known to be effective in pain. A thorough understanding of the options available to physicians is likely to improve pain control and minimize risks.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
Introduction
Chronic pain is one of the greatest health-care crises affecting Americans today. It is a major cause of disability and a leading reason for physician office visits. Moreover, the indiscriminate treatment of chronic pain with systemic opiates has become a major cause of morbidity and mortality. There are close to 16,000 deaths each year attributed to the use of prescription opiates in the United States. It is crucially important for physicians to have an appropriate algorithm for managing patients with pain.
Any strategy begins with a comprehensive evaluation that leads to establishing an accurate diagnosis. To achieve an accurate diagnosis, it is important for caregivers to include a detailed history and physical examination, any necessary imaging, a psychosocial evaluation, understanding the options for patients with chronic pain, and implementing the most conservative options [1]. When the correct diagnosis is made, one can develop the safest and most effective care plan to managing pain.
What Is Pain?
The International Association for the Study of Pain (IASP) defines pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or defined in such terms” [1]. As such, there is typically an emotional component as well as a biologic component of most human pain states [2]. The challenge for the treating physician is to assess the patient from a psychosocial as well as from a biologic perspective and come up with the most appropriate accurate diagnosis, from which a therapeutic plan can be developed.
Physicians need to recognize that pain syndromes are complex and have the ability to treat pain or organize care from a biological, psychological, and social perspective. For most physicians who are trained primarily in the biological approach, it can be challenging to evaluate a patient with severe chronic pain with comorbid psychiatric disorders. In the reverse, many psychiatrists and psychologists who are expert pain clinicians may lack the expertise to diagnose and manage the biological underpinnings. For example, specific nerve injuries can manifest with diffuse pain problems. A clinician needs to be able to recognize these problems and establish the underlying pain generator. Sometimes this will lead to a cure, while at other times the most appropriate management strategy can be achieved.
Patients with similar injuries can present with dramatically different experiences of pain. This can occur for a variety of reasons that are not always evident. For example, some patients with psychological disorders like severe depression and anxiety will frequently present with increased pain beyond what would be expected based on the injury or objective findings. Discrete lesions can be missed, but psychological factors can amplify pain as well. Patients with negative thoughts will experience more pain compared with others with neutral and positive thoughts [3]. On the other extreme, individuals can have genetic disorders leading to lack of pain fibers and experience no pain following an otherwise traumatic injury. These patients with “congenital insensitivity to pain” truly feel no pain [4]. There are multiple gradations in between with sensitivity to nerve injuries.
Pain generally begins in the periphery at specific nociceptors and is conducted to the central nervous system via specific pathways. There is processing and neuromodulation that occurs at the dorsal root ganglion, the spinal cord, and further up the central nervous system [5]. The plasticity that occurs throughout the nervous system has been shown to modify and amplify pain in chronic pain conditions. We have recently learned that at each step along this pathway, the pain signal can be modulated. The pain physician is like a general contractor and should be facile with clinical diagnosis and with the general treatment strategies. If necessary, a pain physician will consult with “subcontractors” who are specialized in addressing focal nerve injury.
If one looks closely enough, most patients we see in clinical practice have an identifiable biologic basis for their pain. However, most patients also have an emotional component that leads to suffering. In some cases this suffering, especially if associated with some psychologic morbidities, can overwhelm the physician. A consultation with psychology should be strongly considered if there is any question of overlapping diagnoses. The job of the pain physician is not only to determine biological source of pain but also to apportion the component of pain that emanates from both the biological underpinnings and the emotional overlay. This evaluation can be quite complex and may involve a more comprehensive evaluation with psychology. In this setting a multidisciplinary evaluation of the patient with pain is recommended.
Diagnostic Workup
This chapter certainly does not attempt to make the reader an expert in all of the different disorders that can cause pain. There are entire treatises devoted to the diagnosis and management of chronic pain [6, 7]. There are no simple X-rays or laboratory tests that indicate if a patient has severe pain. Physicians should, on the other hand, do their best to establish a diagnosis and come up with the most appropriate therapeutic plan. This is achieved by taking a detailed history, performing a physical examination, and obtaining the appropriate workup.
The expectation is understanding that not all patients have a “chronic pain syndrome,” and some present with pure psychological pathology. Rather, in most cases, specific biologic correlates or underpinnings can be identified that may explain a patient’s pain. While most patients do have some component of emotional overlay, psychological morbidity is rarely the primary pathology. Once a diagnosis has been established, a care plan can be formulated. Whenever possible, the source of the pain should be identified, and the clinician-patient team should predetermine a treatment goal. Only with this framework can we expect to come up with an appropriate therapeutic plan.
The complete history and physical examination for all painful disorders is beyond the scope of this chapter. However, the concept of establishing a presumptive diagnosis before embarking on the therapy cannot be overstated. The visit begins with a comprehensive history and physical examination. Prior to considering implementation of a long-term strategy for chronic intractable pain, the physician should establish a diagnosis or at least a presumptive diagnosis. With a diagnosis in hand, one can come up with the most appropriate therapeutic plan [8].
Begin with a chief complaint. Why is the patient here to see you? What is the primary pain problem? The secret to taking a good history is being a good listener. Figure 5.1 illustrates several common pain severity scales utilized to assess pain. During an initial intake, one needs to take a history and understand the inciting events, the time course and character, and the severity of the pain. What makes the pain better or worse? Verbal descriptors of pain, e.g., “burning sensation,” can help determine if the pain is neuropathic or not. Confounding variables, such as work history and satisfaction with the job, will be important as well, and the end result should be a medical documentary of the patient’s pain history. The pain history should include:
-
1.
Anatomic location (body part)
-
2.
Severity (0–10 scale; faces; mild, moderate, severe)
-
3.
Verbal descriptors (shooting or burning, dull or achy)
-
4.
Time course (When is it bad? Does it wax and wane throughout the day, week, or month?)
-
5.
Alleviating factors (What makes it better?)
-
6.
Aggravating factors (What makes it worse?)
-
7.
Changes in functional status caused by pain
-
8.
Review of diagnostic workup (previous EMG, MRI, laboratory tests)
-
9.
Review of the previous treatment (previous surgery, medication, and rehabilitation strategies)
Obtaining a past medical history is part of the comprehensive evaluation for pain. Comorbid diseases can be central in defining a differential diagnosis. Patients with a history of many disorders, including diseases such as cancer or diabetes, can develop painful conditions as a result of the disease or its treatment. A complete understanding of the patient’s history thus can be helpful when trying to establish a diagnosis. For example, patients with uncontrolled diabetes may develop peripheral neuropathies that can be quite painful. The practitioner should understand that part of the treatment of the pain is to work with the primary care physician/endocrinologist to get diabetes under control. As part of the comprehensive evaluation, one should understand what treatments have been tried to date and what the outcome has been of previous treatments. Has a patient previously tried medications, injections, physical medicine modalities, or surgical interventions?
The pain practitioner typically takes a history and follows with a focused physical examination that is determined by the history. This helps the physician narrow the differential, or presumptive, diagnosis. This typically involves inspection, palpation, provocative maneuvers, and a neurologic examination. Laboratory workup can be used to help make a diagnosis or determine if it is safe to proceed with a planned course of therapy. In addition, with the use of some pharmacologic agents, specific laboratory testing may help identify complications that can occur with treatment strategies. More commonly, laboratory workup may be used to determine if it is safe to proceed with interventional pain procedures.
The reason to obtain additional studies is to establish a diagnosis and to help guide the therapy. One should only perform the additional studies below as a guide to therapy. Plain X-rays use X-ray radiation to take a picture of the hard and soft tissue in the spine. These can be helpful in arthritic disorders and evaluating other connective tissues. Flexion-extension films of the spine are taken with patients in multiple positions to assess stability of the spine if a fracture (spondylosis) is suspected. This test also helps to determine spinal instability. In addition, by carefully orienting the patient in the correct plane, fractures and foraminal compromise can be identified and correlated with a patient’s symptoms.
Computed tomography uses a series of X-ray-generated images formatted into two-dimensional and now three-dimensional images of both soft and hard tissues. Scans can help identify hard tissue abnormalities, cancer, and spinal pathology. Ultrasound images internal structures by measuring their capacity to transmit and reflect high-frequency sound waves, making them good for evaluating soft tissue abnormalities. Because of the refractive elements of bony structures, they cannot be used to visualize structures deep to the bony tissue. In the soft tissue, patterns of tears and can be seen in muscles, and abnormal activity can be seen in the soft tissue. This highly sensitivity modality is frequently used to evaluate muscle and ligamentous tears as well as soft tissue structures such as cysts.
Magnetic resonance imaging utilizes strong magnetic fields to assess soft tissues. The detailed images allow for detailed evaluation of the internal soft tissue, such as the nervous tissue or herniated disks in the spine. In the spine, there is clearer definition of the spinal cord, surrounding CSF, and extradural structures, such as disks. Moreover architecture of the disks and level of disk dehydration can be assessed by changes in signal intensity in the spine. MRI with and without contrast will help distinguish malignancy and inflammatory or scar tissues from a re-herniation.
EMG, or electromyography, measures electrical activity within muscles. Various patterns of altered activity can indicate both primary muscle pathology and denervation. Electromyography records voltage changes within a muscle by placing a needle into the muscle. Electrical activity is then recorded in the muscle and displayed on an oscilloscope. Various patterns correlate with diseases of the muscle and other pathologic processes. Nerve conduction velocity (NCV) tests help determine if there is damage along the path of specific nerves. Nerve conduction studies measure velocity and amplitude of electrical activity of the nervous tissue. Abnormalities in electrical activity and conduction can indicate pathology of the nervous tissue, and can be used to identify entrapment syndromes, lesions along the course of a nerve or intrinsic problems within a nerve. The pattern of abnormalities identified can help distinguish between radiculopathies, plexopathies, and primary nerve injuries. These patterns can be used to guide therapy.
Radionucleotide bone scanning is used to assess tissue that has high bone turnover, as seen in fractures, metastatic tumor, and infection. Because this technique is relatively sensitive, it can be used to identify subtle lesions that are missed with other techniques. Biopsy to obtain a tissue diagnosis can be helpful with some neurologic and rheumatologic pain states, visceral pain syndromes, as well as with cancer diagnosis.
In an interventional pain, physicians will also perform diagnostic blocks in order to determine if a structure is involved in pain. This involves placing low volumes of local anesthetic around a peripheral nerve. If pain relief follows a local anesthetic block, an ablative procedure is entertained [11]. For example, diagnostic blocks are frequently performed in the spine (medial branch blocks), viscera (celiac plexus block), or peripheral (specific neural structures, i.e., radial nerve) to determine if the structure innervated by that nerve or plexus is the source of the problem [12]. Table 5.1 illustrates the various types of pain and the associated characteristics. If the practitioner is not clear on the diagnosis, it is appropriate to obtain consultation with pain physicians or members of other specialties.
Treatment Strategies
All too often practitioners may have not established a diagnosis or have an inaccurate diagnosis before beginning treatment. The treatment strategy chosen should be determined after one has established a presumptive diagnosis and a treatment goal. Broadly speaking, there are several general approaches to treating patients with chronic pain. These include medical approaches, anatomic or surgical approaches, neuromodulatory approaches, psychological approaches, alternative approaches, and interventional approaches. Figure 5.2 illustrates a pain treatment ladder that was adapted from the World Health Organization’s pain treatment.
Generally, the practitioner should consider conservative modalities prior to the more invasive options. One should generally have a clinical matrix in place, understanding the risks of the therapies being recommended, the likelihood of curing or managing the problem, the risks of the proposed therapy for any given patient, and the costs of the therapies over both the short and long term. If a patient presents with back pain, it is crucial to understand the pathology, as well as the patient’s comorbid medical disorders, prior to making decisions on the appropriate treatment strategy. A young patient with new onset neurologic deficit, herniated disk, and classic radicular findings may benefit from a micro-diskectomy early in the treatment algorithm. Alternatively an elderly patient with comorbid medical disorders and back pain may benefit from early treatment with physical therapy, chiropractic care, or medication management. Each treatment strategy is based on the judgment of the practitioner and an understanding of the entire clinical picture for an individual patient.
Medication Management
There are several classes of medications frequently used in the treatment of pain. They can be used for a variety of indications (see Table 5.2). Within each class of medication, there are multiple medications that are commonly used as well as numerous side effects and risks that define the category. The class of medication chosen is determined by the patient’s disorder and side effect profile of the agent(s) chosen. For example, neuropathic pain can be most effectively treated with antiepileptic medications and antidepressant medications. If a patient were to present with chronic burning pain and a comorbid depression, the physician may choose an antidepressant class of medication. Severe lancinating pain is more commonly treated with antiseizure medications (see Table 5.3).
Opiates require a specific discussion. Opiates can be used in chronic pain, but there is a paucity of data supporting their use in long-term administration. Lower doses should be considered at early phases as part of a rehabilitative strategy. However, not all patients with chronic pain should be placed on opiates. There are significant risks of systemic opiates that include death. Clinical guidelines support the use of opiates in certain clinical settings [16].
Opioid therapy should be reserved for patients with moderate to severe persistent chronic pain refractory to non-opioid and intervention pain management modalities to improve functioning and quality of life. This should be only started after careful assessment of the risks and benefits of opioid therapy for the individual patient. The initiation, titration, monitoring, and maintenance of opioid medications should only be carried out under the care of an adequately trained pain management specialist and mental health or addiction specialist [17]. Much of what is practiced in the prescribing of opioids for chronic pain has been adapted from experiences with treating cancer pain. The “analgesic ladder” (ref. to fig. or to other chapters) was first introduced by the World Health Organization (WHO) in the 1980s [18]. The short-term (less than 6 months) use of opioids for the treatment of non-cancer chronic pain has been shown to be effective in several systematic reviews. Furlan et al. reviewed 41 randomized trials in 6019 patients suffering from nociceptive, neuropathic, mixed, and fibromyalgia pain and concluded that opioid use over 5–16 weeks was more effective than placebo despite a 33 % dropout rate [19]. Chou and Huffman found opioids to be moderately effective in the treatment of chronic non-cancer pain compared to placebo based on study periods less than 12 weeks [20]. Interestingly, tramadol was the only pain medication to show fair evidence in the treatment of chronic osteoarthritis pain in the systematic review by Manchikanti et al. [21]. In this comprehensive systematic review of 111 trials, only four studies evaluated the effectiveness of opioid use beyond 6 months. Furthermore, Trescot et al. reviewed the efficacy of chronic opioid therapy in terms of functional improvement among chronic pain patients in addition to their pain relief. For treatment of chronic non-cancer pain beyond 6 months, there is a weak evidence supporting morphine and transdermal fentanyl; there is limited evidence for other more commonly used opioids including hydrocodone and oxycodone [22].
Physical Medicine Modalities
Physical modalities include all modalities designed to modify the muscular or painful tendinous insertions. The key pillars in this treatment modality include identifying altered mechanics, promoting healing, and restoring proper mechanics and function. Complimentary treatments such as chiropractic care and acupuncture should be considered along with conventional therapies such as manipulation, physical therapy of the deep tissue including massage, exercise, heat, and cooling, and transcutaneous electric nerve stimulation (TENS) therapy. All of these approaches can be effective for various types of pain.
Psychological Approaches
Many patients with chronic pain can benefit from a comprehensive psychological evaluation. The degree of suffering and comorbid psychologic disorders can be reduced. Biofeedback can decrease arousal of pain and provide additional pain relief. Relaxation techniques such as biofeedback, guided visual imagery, and hypnosis are few of the coping mechanisms that contribute to the multimodal pain treatment strategy. The restoration of sleep in the activity-rest cycle is a key element in the psychosocial component of chronic pain. Treatment is often maintained through self-management interventions that may comprise of scheduled group sessions utilizing the social support and peer interactions.
Cognitive and Behavioral Approaches
An important aspect of treating chronic pain is bridging the gap between patient’s expectations of the treatment plan and the reality of what is actually achieved. Utilizing cognitive behavioral therapy, the focus of pain relief is redirected from “the pain” itself to goal-oriented improvement of function. Negative mechanisms such as catastrophizing are replaced with adaptive and more constructive mechanisms such as self-reassurance. This cognitive restructuring focuses on the value of attitudes, beliefs, and emotional responses to pain and allows the sufferer to resume pleasurable activities and activities of daily living.
Interventional Pain Management
Interventional pain management is the discipline of medicine devoted to the diagnosis and treatment of pain-related disorders, principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment. Interventional pain management techniques are minimally invasive procedures, including percutaneous precision needle placement, with placement of drugs in targeted areas or ablation of targeted nerves, and some surgical techniques, such as laser or endoscopic diskectomy, intrathecal infusion pumps, and spinal cord stimulators, for the diagnosis and management of chronic, persistent, or intractable pain [23]. The lack of knowledge or fear of the risks of some of these techniques leads to over-prescribing of opiate analgesics. Some primary care physicians hesitate to refer out for these procedures, considering them risky or may not know of their efficacy. However, when used judiciously and in appropriate patients, it is possible to decrease the amount of opiates and the complications related to opiates, improve the quality of life, and in some instances improve life expectancy [24, 25].
Epidural Steroid Injections
One of the classic interventional or minimally invasive approaches is epidural steroids, application of small amounts of steroids to specific sites within the epidural space [26]. Usually performed with the aid of fluoroscopic guidance, this technique involves placing a needle into the epidural space. The needle may be placed translaminarly, through the caudal canal, or transforaminally. Each technique can be performed with and without a catheter. Multiple types of steroids, local anesthetics, and contrast are used in the performance of the procedure. It is thought to decrease inflammation, improve pain scores, and function and decrease opiate consumption in patients with acute radiculopathies secondary to disk herniations. They are also infrequently performed in patients with cancer, PHN, and vascular insufficiency pain.
Epidural Infusions of Local Anesthetics
Less frequently, epidural catheters are placed to run an infusion of local anesthetics. The local anesthetic quality can be used to decrease pain and improve function in patients undergoing rehabilitation or in the immediate perioperative period following extremity, abdominal or thoracic surgery, or trauma. This technique has superior pain control over systemic opiates alone. Risks of this technique include epidural bleeding or trauma and should be considered carefully in patients who require anticoagulation.
Sympathetic Ganglion Blocks
Sympathetic blocks are used most frequently in the diagnosis and management of complex regional pain syndrome (formerly known as reflex sympathetic dystrophy or RSD), first reported by Weir Mitchell during the civil war in soldiers who suffered limb injuries. This was later named Sudeck’s dystrophy with observed muscle atrophy and bone demineralization. In 1947, Evans refined the diagnosis with the term reflex sympathetic dystrophy (RSD) with assumed involvement of the sympathetic nervous system with observed abnormal activity in the periphery. It was recently in 2003, the International Association for the Study of Pain (IASP) formed a consensus group in Budapest who outlined the diagnosis criteria for complex regional pain syndrome or CRPS (see Fig. 5.3) [27]. Type I and II differ by the presence (type II) or absence (type I) of named nerve injury. Disproportionate pain is the hallmark of this syndrome that leads to peripheral sensitization and associated with sensory (allodynia), vasomotor (temperature asymmetry), sudomotor (abnormal sweating), motor (atrophy), and trophic (hair and nail growth abnormalities) changes. Variants of complex regional pain syndrome have been described to include sympathetically maintained pain and sympathetically independent pain. Sympathetic blocks are used to distinguish between the two types of the disorder. Table 5.4 describes various treatment options for CRPS including sympathetic nerve block.
Vertebroplasty and Kyphoplasty
This therapy is indicated for patients with focal pain due to a spinal compression fracture. These are minimally invasive, fluoroscopically guided techniques to restore the structural instability of a fractured vertebral body by placing a small amount of bone cement either directly through a cannula. The compressed vertebral body height may be restored during a kyphoplasty by first placing a pneumatic balloon into the crushed vertebrae. This newly created cavity is then filled with bone cement to stabilize the augmented vertebral body. Both of these procedures have been demonstrated to improve pain and decrease opiate consumption in patients with semi-acute and acute vertebral compression fractures (Fig. 5.4) [28].
Minimally Invasive Lumbar Decompression
Minimally invasive lumbar decompression has been recently developed to treat lumbar spinal stenosis as a result of ligamentum flavum hypertrophy. Patients with spinal stenosis present with progressive neurogenic claudication where low back and/or lower extremity pain is exacerbated with standing or walking. This is a minimally invasive, fluoroscopically guided technique for decompressing the narrowed spinal canal by removing portions of the ligamentum flavum through 5 mm trocar sites. This procedure may help chronic pain patients obtain pain relief with less risk than open spinal surgery. Numerous well-controlled trials have been performed with the level one evidence pending [29].
Neuromodulation
Neuromodulation is the field of medicine where electrical energy or medications are targeted to the nervous system through which the conduction of pain signals is modulated and reduced. The use of electricity in the treatment of pain dates back to 46 A.D. where torpedo fish were used by Scribonius Largus to treat headaches. In 1967, Dr. Norman Sheely pioneered the use of electrical leads in the dorsal epidural space to treat intractable cancer pain. This concept has evolved into sophisticated electronic devices that can help patients manage chronic pain. Targeted drug delivery to the intrathecal space was first described by Dr. August Bier in 1898 when he described the first spinal anesthetic [30]. Similarly, the delivery of specific medications has also evolved into the application of implanted computer-controlled pumps capable of delivering precise amounts of analgesic medication(s) to the intrathecal space.
Spinal Cord Stimulation
Spinal cord stimulation involves implanting electrodes into the epidural space to modify pain or disease. The therapy has been demonstrated to be more effective than repeat back surgery and then medication management in the control of pain [31, 32]. Traditional, or tonic stimulation, has been used since the 1960s and is a widely accepted approach to managing neuropathic pain. Traditional stimulation would layer a sensation of “buzzing” over an area of pain, effectively masking the painful sensation with a gentle buzzing sensation. In order to experience pain relief with traditional stimulation parameters, there was a requirement of stimulating the area of pain. Both rechargeable and non-rechargeable power sources have been used to control pain. Figure 5.5 illustrates a typical implanted spinal cord stimulator system. These therapies have been traditionally most effective for neuropathic pain of the trunk and limbs.
New frequencies are also improving the efficacy of spinal cord stimulation. High-frequency spinal cord stimulation involves utilization of frequencies in the 10,000 Hz range and requires a larger energy requirement. It is typically set subthreshold, so the patient feels no paresthesia as they typically do with traditional or tonic stimulation. High-frequency spinal cord stimulation was recently compared to traditional or tonic stimulation in a FDA clinical trial. In a non-inferiority study design, high-frequency stimulation demonstrated superior pain control for both the back and leg over traditional or tonic stimulation [33]. Burst stimulation involves utilizing novel frequencies that have bursts of electrical activity followed by a quiescent period. It is also widely used in Europe and Australia and is the subject of FDA-approved clinical trials in the United States [34].
Novel Targets and Frequencies
Newer stimulation targets or approaches may even improve on the success of traditional spinal cord stimulation. For example, DRG stimulation involves placing the electrodes directly on the dorsal root ganglion (DRG) and stimulating the DRG that is presumed to be involved in the processing of painful stimuli. It appears to be superior to traditional spinal cord stimulation in certain settings [35]. Electrodes are also placed on peripheral nerves in the head and neck to modulate headaches. A novel approach approved in Europe and Australia stimulates the vagus nerve noninvasively as a prophylaxis and treatment for cluster headaches and migraines and has been approved in Europe for GI disorders, asthma anxiety, and depression [36].
Intrathecal Drug Therapy
Intrathecal therapy has been relegated to a salvage approach for most patients with severe cancer and non-cancer-related pain [37]. Intrathecal therapy involves placing a catheter into the intrathecal space and connecting it to an implantable pump to deliver analgesics including opioids. It has been demonstrated to be effective in both cancer and non-cancer populations. In the cancer population, intrathecal opiates have been shown to improve pain with less side effects and possibly improve life expectancy when compared to medical management alone [38]. In addition, when compared to the costs of systemic opiates, intrathecal therapy becomes cost-effective after 28 months. The high upfront costs of the device are offset by the lower costs of maintenance of intrathecal opiates. Furthermore, with close to 16,000 deaths attributed each year to systemic opiates, the overall higher safety profile of controlled delivery is favorable on multiple fronts [39].
In addition, the use of non-narcotics in the intrathecal space to manage severe pain is quite common. Novel agents, including intrathecal ziconotide, have been demonstrated to be effective in patients with severe pain related to cancer and AIDS and in non-cancer-related pain [40, 41]. Algorithms have been developed that guide physicians through various medications [42, 43]. The therapy is widely considered a safe therapy and is used for patients with chronic severe pain who have failed an adequate response to other conservative therapies including low-dose opiate therapy.
Summary
There are multiple treatment strategies that are effective in the management of cancer and non-cancer-related pain. While opiates remain an important tool for physicians, it should not be considered the only tool that physicians have in managing pain. In the treatment of chronic pain, pain should be regarded as the disease state rather than a symptom. Whichever treatment strategy the physician chooses, he/she should begin with a thorough history and physical examination. Based on this, a presumptive diagnosis should be established. This diagnosis thus should lead the physician down an individualized treatment algorithm. The risks of all therapies should be evaluated when developing the appropriate therapeutic plan. All strategies, from simply ignoring the pain to complex surgical procedures, involve some risk. Understanding the treatment options should facilitate treatment with safest and most conservative option, working up in a hierarchical fashion.
Portions of this manuscript have been published in Staats Li Silverman, Alternative options in treating pain (ed Staats PS, Silverman, Controlled Substance Management Springer 2015).
References
Merskey H, Bodguk N. Classification of chronic pain: descriptions of chronic pain syndromes and definition of pain terms. 2nd ed. IASP Press. Seattle. 1994.
Staats PS, Hekmat H, Staats AW. Psychological behaviorism theory of pain: a basis for unity. Pain Forum. 1996;5:194–207.
Staats PS, Staats A, Hekmat H. The additive impact of anxiety and a placebo on pain. Pain Med. 2001;2:267–79.
Thrush D. Congenital insensitivity to pain. Brain. 1973;96:369–86.
Ashburn MA, Staats PS. The management of chronic pain. Lancet. 1999;353:1865–9.
Staats PS, Wallace MS. Pain medicine: just the facts. 2nd ed. McGraw Hill; New York. 2015.
Diwan S, Staats PS. The Diwan Staats atlas pain medicine procedures. McGraw Hill; New York. 2015.
Gupta R, Staats PS. Diagnostic tools in the management of pain. In: Expert pain management. Springhouse Corporation; North Wales. 1997.
Wong DL, Hackenberry-Eaton M, Wilson D, Winkelstein ML, Schwartz P. Wong’s essentials of pediatric nursing. 6th ed. St. Louis; Missouri. 2001, p. 1301.
McCaffery M, Pasero C. Pain: clinical manual. St. Louis; Missouri. 1999, p. 16.
Guarino A, Staats PS. Diagnostic neural blockade in the management of pain. Pain Digest. 1997;7:194–9.
Boswell MV, Singh V, Staats PS, Hirsch JA. Accuracy of precision diagnostic blocks in the diagnosis of chronic spinal pain of facet or zygapophysial joint origin. Pain Physician. 2003;6:449–56.
Benzon HT, et al. Essentials of pain medicine. 3rd ed. Elsevier, Philadelphia. 2011
Krames ES. Intraspinal opioid therapy for nonmalignant pain: current practices and clinical guidelines. J Pain Symptom Manage. 1996;11:333–52.
Stamatos JM, et al. Live your life pain free. Based on the interventional pain management experience of Dr. John Stamatos. McKinney, TX. 2005.
Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician. 2012;15(3 Suppl):S67–116.
Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain. 2009;10:113.
World Health Organization. Cancer pain relief. Geneva: World Health Organization; 1990.
Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic non-cancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J. 2006;174:1589–94.
Chou R, Huffman L. Use of chronic opioid therapy in chronic non-cancer pain: a systematic review. American Pain Society; 2009.
Manchikanti L, Koyyalagunta L, Datta S, et al. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician. 2011;14:91–121.
Trescot AM, Helm S, Benyamin R, et al. Opioids in the management of chronic non-cancer pain: an update of the American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2008;11:S5–62.
MLA citation– Medicare Payment Advisory Commission (U.S.). Report to the Congress: Paying for Outpatient Services In Cancer Hospitals. Washington, DC: MedPac. 2001.
Staats PS. The effect of pain on survival. In: Interventional pain management Anesthesiology Clinics of North America. Guest Ed Staats PS. Philadelphia: Lippincott, Williams and Wilkins, 2003;
Staats PS. Pain, depression and survival. Am Fam Physician. 1999;60:42–4.
Manchikanti L, Staats PS, Nampiaparampil DE. What is the role of epidural injections in the treatment of lumbar discogenic pain: a system 4/2015. Korean J Pain. 2015;28:75–87.
Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;6:326–31.
Anselmetti CG, et al. Percutaneous vertebroplasty in osteoporotic patients: an institutional experience of 1,634 patients with long-term follow-up. J Vasc Intervent Radiol. 2011;22:1714–20.
Benyamin R, Staats PS, Davis K, et al. Accepted for publication. Midas Encore, Pain Physician 2015.
Li S, Staats PS. Permanent implant (intrathecal drug delivery). The atlas of interventional pain care. New York: McGraw-Hill; 2015.
North RB, Kidd DH, Shipley J. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized controlled clinical trial. Neurosurgery. 2007;61:361.
Kumar K, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24 month follow up of the prospective randomized controlled multicenter trial of effectiveness of spinal cord stimulation. Neurosurgery. 2008;63:762–70.
Buyten V, et al. High-frequency spinal cord stimulation for the treatment of chronic back pain patients: results of a prospective multicenter European Clinical Study. Neuromodulation. 2013;16:59–66.
DeRidder D, et al. Burst stimulation for back and limb pain. World Neurosurg. 2013;80:642–9.
Kramer J, Draper CE, Deer TR, et al. Dorsal root ganglion stimulation: anatomy physiology and potential for therapeautic targeting in chronic pain. In: Diwan S, editor. The Diwan Staats Atlas of pain medicine procedures. McGraw Hill; New York. 2015. p. 626–31.
Deer TR, Mekhail N, Petersen E, Krames E, Staats P, Pope J, Saweris Y, Lad SP, Diwan S, Falowski S, Feler C, Slavin K, Narouze S, Merabet L, Buvanendran A, Fregni F, Wellington J, Levy RM. The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation. 2014;17:551–70.
Pope J, Deer T, McRoberts WP. The Burden of being positioned as a salvage therapy. Pain Med. 2015;16(10):2036–8.
Smith TJ, Coyne PJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Català E, Bryce DA, Cousins M, Pool GE. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol. 2005;16:825–33.
Kumar K, et al. Treatment of chronic pain by using a intrathecal drug delivery compared to conventional treatments. A cost effectiveness analysis. J Neurosurg. 2002;97:803–10.
Staats PS, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled clinical trial. JAMA. 2004;1:291.
Wallace MS, Charapata S, Fisher R, Staats PS, et al. The Ziconotide Nonmalignant Pain Study Group. Intrathecal Ziconotide in the treatment of chronic nonmalignant pain: a randomized double blind placebo controlled trial. Neuromodulation. 2006;9:75–86.
Prager J, Deer T, Levy R, et al. Best practices for intrathecal drug delivery for pain. Neuromodulation. 2014;17(4):354–72.
Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, Caraway D, Cousins M, De Andrés J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, McDowell II GC, Panchal S, Rauck R, Saulino M, Sitzman BT, Staats P, Stanton-Hicks M, Stearns L, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by Intrathecal (Intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodul Technol Neural Interface. 2012;15:436–66.
WHO’s pain ladder for adults. World Health Organization Web site. http://www.who.int/cancer/palliative/painladder/en/#. Accessed May 5 2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Staats, P.S., Li, S. (2017). Evaluation and Management of Chronic Pain. In: Elkwood, A., Kaufman, M., Schneider, L. (eds) Rehabilitative Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-41406-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-41406-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41404-1
Online ISBN: 978-3-319-41406-5
eBook Packages: MedicineMedicine (R0)